CDCM 9th Annual Symposium
The symposium is now over. Thank you for joining us!
Join us on February 26, 2025 for the CDCM's 9th annual symposium and learn about new cell, gene, and regenerative medicine discoveries, pre-clinical development and clinical trials of curative medicines, and challenges with bringing these cures to patients to meet unmet medical needs. Exploration and discussion of these topics will be held at this one-day conference for clinicians, basic scientists, patient advocates, translational investigators, and biotech and pharmaceutical experts. More than 700 people are expected to attend, including a growing number of international participants from Europe, Asia Pacific, and the Middle East.
Please contact us @ nickxyu@stanford.edu if you require an accommodation.
Each year, the CDCM hosts a symposium to engage in scientific discussion about new discoveries and developments in the cell and gene therapy field. The 9th annual symposium will host speakers to present on topics related to the field, including new cell, gene, and regenerative medicine discoveries; pre-clinical development and clinical trials of curative medicines; and challenges with bringing these cures to patients with unmet medical needs.
This year's host of renowned speakers so far include:
- George Church, PhD, Professor of Genetics, Harvard Medical School (Virtual Presentation)
- Everett Meyer, MD, Associate Professor of Medicine, Pediatrics – Stem Cell Transplantation, Stanford University
- Kapil Bharti, PhD, NEI Scientific Director, Ocular and Stem Cell Translational Research Section, National Institutes of Health
- Peter Marks, MD, PhD, Director, The Center for Biologics Evaluation and Research, Food and Drug Administration
- Siddhartha Jaiswal, MD, PhD, Assistant Professor of Pathology, Stanford University
- David Miklos, MD, PhD, Chief of BMT and Cell Therapy Program, Stanford University
- Joseph C. Wu, MD, PhD, Director, Stanford Cardiovascular Institute, Stanford University
- Mark A. Skylar-Scott, PhD, Assistant Professor of Bioengineering, Stanford University
- Keiichi Fukuda, MD, PhD, FACC, Founder and CEO, Heartseed
- Anthony Atala, MD, W. Boyce Professor and Chair of Urology, Wake Forest University
- Keith Van Haren, MD, Associate Professor of Neurology and Neurological Sciences, Stanford University
- Edward Neilan, MD, PhD, Chief Medical and Scientific Officer, National Organization for Rare Disorders
- Carolina Tesi-Rocha, MD, Clinical Professor of Neurology, Stanford University
- Sergiu P. Pasca, MD, Kenneth T. Norris Professor, Stanford University
Additionally, the symposium will be highlighting 2 products that were developed by the CDCM and tell the story from the bench to bedside. Two panels will take place in the symposium, discussing treatment programs which were spearheaded at Stanford University.
Agenda
Platinum Sponsor
Gold Sponsors
Silver Sponsors
